Given that cocaine induces neuroadaptations through regulation of gene expression, we investigated whether chromatin remodeling at specific gene promoters may be a key mechanism. We show that cocaine induces specific histone modifications at different gene promoters in striatum, a major neural substrate for cocaine's behavioral effects. At the cFos promoter, H4 hyperacetylation is seen within 30 min of a single cocaine injection, whereas no histone modifications were seen with chronic cocaine, consistent with cocaine's ability to induce cFos acutely, but not chronically. In contrast, at the BDNF and Cdk5 promoters, genes that are induced by chronic, but not acute, cocaine, H3 hyperacetylation was observed with chronic cocaine only. DFosB, a cocaine-induced transcription factor, appears to mediate this regulation of the Cdk5 gene. Furthermore, modulating histone deacetylase activity alters locomotor and rewarding responses to cocaine. Thus, chromatin remodeling is an important regulatory mechanism underlying cocaine-induced neural and behavioral plasticity.
Introduction
Acute and chronic exposure to cocaine alters gene expression in striatum, a major neural substrate for the rewarding and locomotor-activating effects of psychostimulants and other drugs of abuse (Hyman and Malenka, 2001; Nestler, 2001; Yuferov et al., 2003; Kalivas, 2004; Yao et al., 2004) . The Fos family of transcription factors has been implicated as important mediators of some of these drug-induced changes in gene expression. Drugs of abuse rapidly but transiently induce cFos and several other Fos family proteins in striatum after acute administration (Graybiel et al., 1990; Young et al., 1991) . In contrast, chronic drug exposure desensitizes the induction of most of these genes (Hope et al., 1992; Daunais et al., 1993; Persico et al., 1993) and leads instead to the selective accumulation of DFosB, a truncated splice variant of the FosB gene (Hope et al., 1994; Moratalla et al., 1996; Hiroi et al., 1997) . Induction of DFosB appears to mediate enhanced sensitivity and drive for cocaine and other drugs of abuse in animal models of drug addiction (Kelz et al., 1999; Nestler et al., 2001; Colby et al., 2003; Peakman et al., 2003) , and progress has been made in identifying some of the target genes through which DFosB produces this behavioral plasticity (Ang et al., 2001; Bibb et al., 2001; McClung and Nestler, 2003) . However, the molecular mechanisms underlying the in vivo regulation of specific target genes by DFosB and other drug-induced transcription factors remain unexplored.
The goal of this study was to examine these next levels of transcriptional mechanisms underlying chronic cocaine action. Increasing evidence from other fields suggests that transcription factors regulate target genes by recruiting to the gene promoters two different classes of enzymes: (1) enzymes that modify the core histones and other chromatin components by regulating their acetylation, phosphorylation, methylation, etc. (e.g., histone acetyl transferases [HATs] and histone deacetylases [HDACs] ), and (2) enzymes that alter the structure of chromatin by disrupting the nucleosome in an ATPdependent manner (e.g., the SWI-SNF [mating switching and sucrose nonfermenting] complex) (for review, see Jenuwein and Allis, 2001; Turner, 2002; Felsenfeld and Groudine, 2003) . These enzymes act on a target promoter and thereby increase or decrease expression of that gene. For example, the acetylation of histones H3 and H4, as well as phosphoacetylation of H3, at gene promoters is linked to increased gene activity, while deacetylation is linked with suppression and silencing of gene activity. Recent evidence indicates that histone acetylation-deacetylation is regulated in adult neurons in association with learning and memory (Guan et al., 2002; Alarcon et al., 2004; Korzus et al., 2004; Levenson et al., 2004) and in response to seizures (Huang et al., 2002; Tsankova et al., 2004) and psychotropic drugs (Li et al., 2004) . Moreover, HDAC inhibitors have shown promise as potential therapeutic agents in animal models of Huntington's disease (Steffan et al., 2001; Hockly et al., 2003; Mattson, 2003) and spinal muscular atrophy (Chang et al., 2001; Minamiyama et al., 2004) . These data support the view that the acetylation of core histones may be a critical determinant of gene expression in brain.
Here, we focused on several gene promoters known to be regulated in striatum by acute or chronic cocaine, and utilized chromatin immunoprecipitation (ChIP) assays to investigate mechanisms of chromatin remodeling associated with drug action. We chose gene promoters that represent distinct drug mechanisms: cFos is activated by acute cocaine, but desensitized by chronic cocaine, while BDNF and Cdk5 are activated chronically but not acutely. In addition, induction of the Cdk5 gene appears to be mediated by DFosB, whereas BDNF is regulated independently of DFosB by still unknown mechanisms.
Findings from this study describe prominent alterations in histone modifications and other mechanisms of chromatin remodeling in striatal neurons that are associated with cocaine regulation of specific genes and directly implicate these mechanisms in cocaine-induced neural and behavioral plasticity.
Results

Quantification of Cocaine-Induced Histone Modifications by Chromatin Immunoprecipitation Assays
To better understand the molecular actions of cocaine, we studied histone modifications at the promoter regions of the cFos, FosB, BDNF, and Cdk5 genes in rat striatum after acute or repeated cocaine administration. To clearly differentiate between acute and chronic cocaine effects, we analyzed histone modifications at several different time points after cocaine administration. Striatal punches were fixed in 1% formaldehyde to crosslink proteins bound to DNA in vivo. The crosslinked chromatin was then sheared to fragments of w500 bp in length via sonication. We then performed ChIP assays with antibodies against acetylated H4, acetylated H3, or phosphoacetylated H3 and quantified the amount of DNA associated with the modified histones using realtime PCR.
Several controls were performed to confirm the specificity and validity of the assay (Figure 1 ). To control for the specificity of antibody binding, we immunoprecipitated chromatin samples with nonimmune IgG, which precipitated negligible levels of the various genes studied ( Figure 1A ). To ensure that our technique would allow us to measure acetylation of histones only at transcriptionally active regions in the genome where acetylation is present in vivo, we confirmed that acetylation is absent in striatum at transcriptionally silenced genes, such as the b-globin gene ( Figure 1A ), which is inactivated within neurons early in development, and on genes (e.g., tyrosine hydroxylase) whose expression is (A) Levels of acetylated H4 (acH4) at the cFos and several other gene promoters in striatum of rats treated acutely with saline or cocaine and analyzed 30 min later were quantified using real-time PCR, by comparing relative Ct values for the various genes of interest. Parallel experiments, not shown, were carried out for acetylated and phosphoacetylated H3. Ct values of immunoprecipitated samples (saline control versus cocaine) were normalized to Ct values obtained from ''input'' or nonimmunoprecipitated DNA. The figure shows increased levels of the cFos promoter in anti-acetylated H4 immunoprecipitates after cocaine treatment (Ct values of 28.08 for control, and 26.68 for cocaine, indicating a w2.5-fold increase with cocaine). Immunoprecipitation with nonimmune IgG yielded much higher Ct values (w37) indicating almost no precipitation of the cFos promoter in the absence of a specific antibody. In contrast to the cFos promoter, acute cocaine, chronic cocaine, or selfadministered cocaine (Self Adm) , had no effect on levels of several other gene promoters in anti-acH4 or anti-acH3 immunoprecipitates, including the b-tubulin promoter (A and B), the b-globin promoter (A), the tyrosine hydroxylase (TH) promoter (C), and the H4 promoter (D). Data are expressed as mean 6 SEM (n = 6-8).
Neuronhigh in other brain regions but absent from striatum (Figure 1C) . Finally, we measured levels of histone acetylation in striatum at the promoters of the b-tubulin ( Figure  1B ) and core histone H4 genes ( Figure 1D ), which are expressed in adult striatum but have expression levels that are unchanged by acute and chronic cocaine (McClung and Nestler, 2003; Yuferov et al., 2003) . As expected, levels of histone modifications at these two promoters did not differ between control and acute or chronic cocainetreated animals. These findings indicate that the observed changes in histone modifications at the cFos, FosB, BDNF, and Cdk5 genes, presented below, are not global, but are limited to genes with expression that varies as a result of cocaine exposure.
Cocaine Regulation of Histone Modifications at the cFos and FosB Promoters We first assayed histone modifications at the cFos promoter after acute and chronic cocaine. As shown in Figures 2A-2C , we found that acute cocaine causes the robust induction of both H4 acetylation and H3 phosphoacetylation, but not of H3 acetylation alone, at the cFos promoter as early as 30 min after drug administration. All of these effects reverted to control levels within 3 hr and remained unchanged 24 hr after drug administration. Acute administration of amphetamine, a related psychostimulant, caused a similar pattern of histone modifications at the cFos promoter (data not shown). These findings of rapid and dramatic histone modifications at the cFos gene in striatum in response to acute psychostimulants are consistent with the fact that cFos is an immediate early gene, which is known to be activated very rapidly after acute administration of these drugs of abuse (Graybiel et al., 1990; Young et al., 1991; Hope et al., 1992) .
Very different results were obtained after a course of chronic cocaine administration. Under these conditions, levels of H4 and H3 acetylation ( Figure 2D ) and of H3 phosphoacetylation (data not shown) were unchanged compared to saline controls, both 1 hr and 24 hr after the last cocaine dose. The lack of induction of histone modifications at the cFos promoter at the 1 hr time point represents the complete desensitization of histone acetylation after chronic exposure to cocaine and is consistent with earlier observations that induction of cFos mRNA is similarly desensitized after chronic psychostimulant exposure (Hope et al., 1992; Daunais et al., 1993; Persico et al., 1993) .
We next examined cocaine regulation of histone modifications at the FosB gene promoter. Like cFos, fulllength FosB mRNA is induced rapidly and transiently by acute cocaine, but unlike cFos shows only partialnot complete-desensitization after chronic cocaine administration (Hope et al., 1992 (Hope et al., , 1994 Chen et al., 1995) . The FosB gene was also of interest, because it encodes DFosB, whose mRNA is induced rapidly and transiently by acute cocaine and shows only partial desensitization with chronic cocaine, but DFosB protein accumulates uniquely during a course of chronic cocaine administration due to the stability of the protein (Chen et al., 1995 (Chen et al., , 1997 Nestler et al., 2001) . Analysis of histone modifications at the FosB promoter showed similarities to those observed at the cFos promoter after acute cocaine (Figure 3A) , but the modifications were strikingly different after chronic cocaine ( Figure 3B ). Thus, we observed induction of H4 acetylation, but no change in H3 acetylation or phosphoacetylation (data not shown), at the FosB promoter after acute cocaine administration. In contrast, the FosB promoter showed significant induction of H3 acetylation, but not H3 phosphoacetylation or H4 acetylation, at 1 hr after the last dose of a chronic cocaine regimen ( Figure 3B ). These data are consistent with earlier observations that induction of FosB and DFosB mRNA, in contrast to cFos mRNA, only partially desensitizes with chronic cocaine administration (Chen et al., 1995) .
To determine whether these effects of chronic investigator-administered cocaine on histone modifications at the cFos and FosB promoters are relevant to cocaine addiction, we determined whether similar modifications occur after chronic self-administration of the drug. Indeed, chronic self-administration of cocaine in rats was associated with no histone modifications at the cFos promoter (data not shown), but with dramatic induction of H3 acetylation, but not H4 acetylation, at the FosB promoter ( Figure 3C ).
Cocaine Regulation of Histone Modifications at the BDNF and Cdk5 Promoters Unlike cFos, which is induced by acute, but not chronic, cocaine, BDNF and Cdk5 are examples of genes that are induced by chronic, but not acute, cocaine administration (Bibb et al., 2001; Grimm et al., 2003; McClung and Nestler, 2003) . Whereas a single dose of cocaine did not produce any significant histone modifications at the BDNF or Cdk5 promoters (data not shown), we found dramatic regulation at these promoters after chronic cocaine (Figure 4 ). Chronic cocaine robustly induced levels of H3 acetylation at the BDNF and Cdk5 promoters in striatum, with no changes seen in H4 acetylation. Strikingly, this induction of H3 acetylation was observed 24 hr after the last dose of cocaine (Figures ChIP was performed on striata of chronic cocaine-and saline-treated rats (used 24 hr after the last injection) with anti-acetylated H4 (acH4), anti-acetylated H3 (acH3), or antiphosphoacetylated H3 (pacH3) antibodies, and levels of the BDNF (A) or Cdk5 (B) promoters in the immunoprecipitates were measured using real-time PCR. Results are not shown for pacH3, since Ct values were virtually as high as those seen for nonimmune IgG and were unaffected by cocaine exposure. There was also no effect of acute cocaine on association of the BDNF or Cdk5 promoters with these various histone modifications (data not shown). Data are expressed as mean 6 SEM (n = 6-8). *p < 0.05, Student's t test. ChIP was performed on striata of cocaine-treated and control rats with anti-acetylated H4 (acH4), anti-acetylated H3 (acH3), or anti-phosphoacetylated H3 (pacH3) antibodies, and levels of the FosB promoter in the immunoprecipitates were measured with real-time PCR. (A) shows histone modifications 1 hr after acute cocaine or saline; (B) shows histone modifications 1 hr after the last injection of chronic cocaine or saline; and (C) shows histone modifications 24 hr after the last cocaine or saline self administration (Self Adm). Results are not shown for pacH3, since Ct values were virtually as high as those seen for nonimmune IgG and were unaffected by cocaine exposure. Data are expressed as mean 6 SEM (n = 6-8). *p < 0.05, Student's t test.
4A and 4B), suggesting relatively long-lived adaptations at these promoters in contrast to what was seen with acute cocaine at the cFos promoter. An even more dramatic selective increase in H3 acetylation levels was seen at the BDNF and Cdk5 promoters 24 hr after the last session of chronic self-administration of cocaine ( Figure 4) .
To examine the longevity of increased H3 acetylation at the BDNF and Cdk5 gene promoters, we analyzed striatal samples after 1 week of withdrawal. Interestingly, the level of acetylated H3 at the BDNF promoter was strikingly high at this time point (14.1 6 3.6-fold; p < 0.05) compared to the w3-fold increase seen after 1 day of withdrawal. Thus, histone modifications at the BDNF promoter are very long-lasting and even build over the course of withdrawal. This pattern of H3 acetylation at the BDNF gene is interesting in light of findings that levels of BDNF protein in this region increase further as a function of withdrawal (Grimm et al., 2003) . In contrast, the level of acetylated H3 at the Cdk5 promoter remained elevated after 1 week of withdrawal (1.9 6 0.5-fold), but this effect was no longer statistically significant. This suggests that histone modifications at the Cdk5 gene are beginning to return to normal at this time point.
Role for DFosB in Cocaine Regulation of the Cdk5 Gene Previous work has suggested that Cdk5 is one target gene through which DFosB produces its long-lasting effects on hippocampal and striatal function (Bibb et al., 2001; Chen et al., 2000; Peakman et al., 2003) . This is based partly on the observations that DFosB overexpression induces Cdk5 in striatum, while a dominant negative antagonist blocks cocaine induction of Cdk5. Cdk5 is a particularly interesting target gene, since recent evidence has implicated it in mediating the ability of chronic cocaine to induce the outgrowth of dendritic arborizations of striatal neurons (Norrholm et al., 2003) . However, direct evidence that DFosB's regulation of Cdk5 in striatum represents a direct effect on the Cdk5 gene promoter has been lacking. Indeed, there remains some controversy in the field as to whether DFosB regulates gene expression directly or, rather, indirectly by interfering with the actions of other transcription factors (see Andersson et al., 2001; Nestler et al., 2001) . It was, therefore, important to use ChIP assays to gain further insight into mechanisms governing regulation of the Cdk5 gene in vivo. First, we carried out ChIP assays using an anti-DFosB antibody to immunoprecipitate chromatin fragments from striata of control and chronic cocaine-treated rats. As predicted, we found a w3-fold increase in the association of DFosB with the Cdk5 gene promoter after chronic cocaine exposure ( Figure 5A ). In contrast, there was no evidence of increased association of DFosB with the BDNF gene (data not shown), consistent with reports that BDNF expression is not affected by DFosB in striatum (McClung and Nestler, 2003) . We know that DFosB, and not fulllength FosB, is the protein associating with the Cdk5 gene promoter, since no effect was seen using an antibody that recognizes full-length FosB but not DFosB. These findings demonstrate that, after chronic cocaine administration, the Cdk5 gene in striatum shows signs of transcriptional activation (i.e., increased H3 acetylation) as well as increased association with DFosB.
Second, we analyzed striatum from a line of bitransgenic mouse that inducibly overexpresses DFosB with some selectivity in striatum (Kelz et al., 1999) . This mouse uses the tetracycline gene regulation system to maintain DFosB so that it is turned off during development and to turn it on in striatum of adult animals. We found that induction of DFosB in these mice, which induces Cdk5 mRNA and protein expression (Bibb et al., 2001) , was associated with a w3-fold increase in association of DFosB with the Cdk5 promoter in striatum ( Figure 5B ). In contrast, no effect was seen at the BDNF promoter (data not shown). This further supports the notion that DFosB interacts directly with the Cdk5 gene in striatum in vivo.
Having established evidence that the Cdk5 gene is activated in striatum in vivo by chronic cocaine and that this effect may be mediated, at least in part, via DFosB, we examined whether another class of chromatin remodeling protein, SWI-SNF, is also involved. Brg1 is the core ATPase of this multisubunit chromatin Figure 5 . Role of DFosB in Regulation of the Cdk5 Gene Promoter in Striatum (A) ChIP was performed on striata of chronic cocaine-and saline-treated rats (used 24 hr after the last injection) with anti-DFosB, anti-full length FosB, or anti-Brg1 antibodies, and levels of the Cdk5 promoter in the immunoprecipitates were measured using real-time PCR. (B) ChIP was performed on striata of inducible bitransgenic mice either expressing (+DFosB) or not expressing (2DFosB) DFosB with anti-DFosB, anti-full length FosB, or anti-Brg1 antibody, and levels of the Cdk5 promoter in the immunoprecipitates were measured with real-time PCR. Data are expressed as mean 6 SEM; n = 6-8. *p < 0.05, Student's t test.
remodeling complex, which is implicated in the regulation of many mammalian genes (Neely and Workman, 2002; Kadam and Emerson, 2003) . We found that immunoprecipitation of chromatin fragments from striatum with anti-Brg1 antibody revealed a several-fold greater association of Brg1 with the Cdk5 gene promoter in striatum of mice expressing DFosB compared with littermate control mice ( Figure 5B ). A similar effect was seen in striatum of chronic cocaine-treated rats, where the association of Brg1 with the Cdk5 promoter was several-fold higher compared with saline-treated controls ( Figure 5A ). Together, these findings provide several lines of important evidence that DFosB induces the Cdk5 gene in the brain in vivo via direct activation of the gene promoter.
In contrast to Cdk5, there was no change in the association of Brg1 with the BDNF promoter after chronic cocaine (data not shown). These findings further indicate that different genes activated in striatum by chronic cocaine are activated via fundamentally distinct mechanisms. These in vivo findings are consistent with a recent report in cell culture, which shows distinct SWI-SNF complexes, some containing Brg1 and others containing different factors, directing promoter-specific regulation of target genes (Kadam and Emerson, 2003) .
Regulation of the Biochemical and Behavioral
Actions of Cocaine by the HDAC Inhibitor, Sodium Butyrate Levels of histone acetylation in intact cells can be increased by use of HDAC inhibitors, which are being developed as pharmaceutical treatments of diverse disorders (see Discussion). We used sodium butyrate, a widely used-albeit nonspecific-HDAC inhibitor, validated in cultured cells and peripheral tissues, to determine whether it can influence levels of histone acetylation in brain. We measured levels of H3 phosphoacetylation using immunohistochemical analysis of brain sections in response to cocaine with and without the co-administration of sodium butyrate. (We could not use the antibodies to acetylated H4 or H3 because they do not work for immunohistochemistry [data not shown].) Systemic administration of sodium butyrate at a dose of 200 mg/kg did not influence overall levels of H3 phosphoacetylation in striatum (Figure 6 ). Cocaine alone (at a dose of 15 mg/kg i.p.) caused a significant Figure 6 . Effect of the HDAC Inhibitor, Sodium Butyrate, on Biochemical Responses to Cocaine Rats were treated with two i.p. injections, administered 15 min apart, and were used 30 min after the second injection. Rats received two saline injections (D), sodium butyrate (200 mg/kg) followed by saline (B), saline followed by cocaine ([C], 15 mg/kg), or sodium butyrate (200 mg/kg) followed by cocaine (A). For comparison, two additional groups of rats, administered saline followed by caffeine (10 mg/kg) or sodium butyrate followed by caffeine, were analyzed. Brain sections were stained immunohistochemically with anti-phosphoacetylated H3 antibody followed by a cy3-labeled secondary antibody (A-D) or HRP-tagged secondary antibody analyzed with DAB staining for quantitation (E). Results shown in the figure are representative of multiple sections obtained from four rats in each treatment group. Bar graphs represent the mean 6 SEM. *p < 0.05 compared to Sal/Sal, **p < 0.05 compared to Sal/Coc, Student's t test. (F) and (G) show the levels of cFos mRNA quantitated by RT-PCR and levels of phosphoacetylated H3 at the cFos promoter, by ChIP and real-time PCR, respectively. Sodium butyrate (200 mg/kg), given in conjunction with cocaine (15 mg/kg), induced significantly higher levels of cFos mRNA (F) and phosphoacetylated H3 at the cFos gene (G) in striatum compared to levels in rats given cocaine alone. Sodium butyrate by itself had no effect on cFos mRNA or H3 phosphoacetylation at the cFos gene. Data are expressed as mean 6 SEM (n = 4-6 in each treatment group). *p < 0.05 compared to Sal/Sal, **p < 0.05 compared to Sal/Coc, Student's t test.
increase in H3 phosphoacetylation. Strikingly, administration of sodium butyrate followed by cocaine caused a more dramatic induction of H3 phosphoacetylation in striatum ( Figure 6 ). This synergistic interaction between sodium butyrate and cocaine was apparent not only by the increased number of cells positive for H3 phosphoacetylation (Figure 6 ), but also by the increased intensity of staining within each positive cell. These findings demonstrate that sodium butyrate augments the ability of cocaine to induce histone modifications in striatum. The effects seen in striatum were not apparent throughout the brain; for example, no obvious effect was evident in frontal cortex, septum, or other neighboring brain regions (data not shown). The lack of regulation seen in these other regions presumably represents a limit of detection, since cocaine is known to alter gene expression in some of these other brain regions (see Kalivas, 2004) , albeit to a lesser extent than in striatum, due to the lower levels of the dopamine transporter (target of cocaine) in these various regions.
The cocaine-induced increase in H3 phosphoacetylation in striatum was selective for this psychostimulant. Caffeine, at a dose (10 mg/kg) that causes the same level of locomotor activation as cocaine (Self et al., 1996) , failed to activate H3 phosphoacetylation in striatum, even when it was injected in conjunction with sodium butyrate ( Figure 6E ). This finding also indicates that increased phosphoacetylation of H3 in striatum is not a consequence of increased locomotor activity per se.
Having established that sodium butyrate promotes cocaine-induced histone modifications in striatum, it was of interest to study the effect of this HDAC inhibitor on cocaine regulation of the cFos gene. We found that administration of sodium butyrate 15 min prior to cocaine administration increased the degree of induction of cFos mRNA expression in striatum ( Figure 6F ). Sodium butyrate alone had no effect. Similarly, sodium butyrate potentiated the ability of cocaine to induce association of phosphoacetylated H3 with the cFos gene promoter ( Figure 6G ).
We next investigated whether the enhancement of cocaine's effects on histone modifications and gene regulation in striatum by sodium butyrate is associated with alterations in cocaine's behavioral effects. To address this question, animals were given sodium butyrate at the lower dose of 100 mg/kg followed by cocaine 15 min later. This dose of sodium butyrate by itself had no effect on the animals' locomotor activity, but enhanced the locomotor-activating effects of cocaine (Figure 7 ). This effect was more apparent on the second day of cocaine exposure, when sodium butyrate nearly doubled the locomotor activation induced by cocaine ( Figures 7C and 7D) .
Regulation of Cocaine Reward by HDAC Inhibition or Overexpression
We used the conditioned place preference (CPP) paradigm, in which animals learn to prefer an environment paired with cocaine, to study the influence of histone Rats were habituated to the locomotor chambers for 30 min, were given sodium butyrate (NaBt, 100 mg/kg i.p.), and 20 min later were given cocaine (15 mg/kg i.p.). This regimen was repeated the following day. Line graphs represent the number of ambulatory counts recorded in 5 min bins (mean 6 SEM). Bar graphs represent total activity. *p < 0.05 compared to saline/saline, #p < 0.05 compared to saline/cocaine. In saline-cocaine and butyrate-cocaine groups, n = 16; n = 8 in saline-saline and butyrate-saline groups. Error bars indicate the mean 6 SEM. acetylation on cocaine reward. We first used the HDAC inhibitor, trichostatin A (TSA), which is structurally distinct from butyrate and has been widely validated as an HDAC inhibitor. As with butyrate, we found that systemic administration of TSA enhances H3 phosphoacetylation seen in striatum in response to cocaine (data not shown). As shown in Figure 8B , TSA administration also increased the rewarding effects of cocaine, as indicated by enhanced place conditioning to a moderate cocaine dose. These findings further substantiate our observations that HDAC inhibition promotes the behavioral actions of cocaine.
To gain further insight into these phenomena, we used a Herpes Simplex Virus (HSV) vector to overexpress a particular subtype of HDAC, HDAC4, directly in striatum. GFP was expressed as a control. We targeted the ventral portion of striatum, the nucleus accumbens, which is most closely associated with the rewarding effects of cocaine. We chose HDAC4 because it is highly expressed in brain and because we found in preliminary experiments that it is highly expressed within striatum. We found that overexpression of HDAC4 in striatum dramatically decreased the rewarding effects of cocaine in the place conditioning assay in comparison with control animals that received injections of HSV-GFP ( Figure 8A ). We also showed that HDAC4 overexpression reduced levels of H3 acetylation in the tissue, as would be expected (data not shown). As with several other HSV vectors (e.g., see Carlezon et al., 1998; Barrot et al., 2002) , we found high levels of HDAC4 overexpression in a w1 mm 3 area around the injection site. HDAC4 overexpression was not associated with any detectable toxicity, assessed by Nissl staining and GFAP immunohistochemistry, beyond that seen with injections of vehicle alone (data not shown).
Discussion Cocaine Induces Acetylation and Phosphoacetylation of Histones at Specific Gene Promoters
In this study we demonstrate that acute and repeated cocaine administration induces prominent alterations in the N-terminal tails of H3 and H4 associated with specific gene promoters. The clinical relevance of the chronic cocaine effects on histone modifications is supported by our observations that the chronic selfadministration of cocaine results in equivalent regulation. Our data reveal an interesting phenomenon: the acute effects of cocaine are associated predominantly with acetylation of H4 (cFos and FosB), whereas chronic effects of cocaine are restricted to acetylation of H3 (FosB, Cdk5, and BDNF). In addition, phosphoacetylation of H3 was seen for the acute induction of the cFos promoter only. This switch from H4 acetylation acutely to H3 acetylation chronically holds even for individual genes that are induced under both conditions: for example, acute induction of FosB involves H4 acetylation, whereas chronic induction of the gene involves H3 acetylation. These patterns of histone modifications are generally consistent with those observed recently in hippocampus in response to acute and chronic seizures: acute regulation is associated with H4 acetylation and, for cFos, with phosphoacetylation of H3 as well, while chronic regulation is associated with H3 acetylation (Crosio et al., 2003; Tsankova et al., 2004) . Together, these findings begin to provide a general scheme of how histones are covalently modified in brain in response to acute and chronic perturbation.
The phosphoacetylation of histone H3 (i.e., phosphorylation at Ser10 and acetylation at Lys14) was seen only for the cFos promoter. As stated above, this was the case for cocaine in striatum, as well as for seizures and for activation of several signaling pathways in hippocampus (Crosio et al., 2003; Tsankova et al., 2004) . For all other promoters studied here and previously, the Ct values from samples pulled down by antiphosphoacetylated H3 were very high, close to the Ct values obtained with nonimmune IgG. This is true even for other genes (e.g., FosB and BDNF), which, like cFos, are considered immediate early genes on the basis of their rapid induction. However, these other genes, while induced rapidly, are not induced to nearly the same degree or with the same rapidity as cFos. This suggests that phosphoacetylation of H3 may be relatively specific for the cFos gene and related to the unique rapidity and magnitude of its induction. Earlier work has shown desensitization of cFos after chronic administration of cocaine or other drugs of abuse (Hope et al., 1992; Daunais et al., 1993; Persico et al., 1993) . We found that this desensitization corresponds to the loss of H4 acetylation and H3 phosphoacetylation seen at the cFos promoter after the first cocaine exposure. In contrast, at another Fos family promoter, FosB, cocaine continues to induce histone modifications (H3 acetylation) even after prior chronic exposure to the drug, indicating that the FosB gene still shows evidence of gene activation. This is consistent with our proposed model for DFosB: that each drug exposure continues to induce the FosB gene, which allows its stable gene product, Mice were injected with HSV-HDAC4 or HSV-GFP into the nucleus accumbens and then assessed for place conditioning to cocaine (5 mg/kg i.p.). In parallel experiments, mice were treated with TSA (0.2 mg/kg i.p.) or DMSO vehicle prior to each cocaine dose during place conditioning to cocaine (5 mg/kg). CPP score represents the time (in seconds) that animals spend in the cocaine-paired chamber posttraining versus pretraining. Overexpression of HDAC4 (n = 8) dramatically blocked cocaine place conditioning compared to findings in GFP-expressing control animals (n = 8). Conversely, TSA increased cocaine place conditioning compared to vehicle-treated controls (n = 12 in each group). Bar graphs represent the mean 6 SEM. *p < 0.05, Student's t test. Note that the same dose of cocaine used in both experiments caused different levels of place preference in control animals; this is due to the known sensitizing effect of intracranial surgery on this measure (see Carlezon et al., 1998) .
DFosB, to accumulate in striatal neurons, where it becomes a key mediator of the drug-addicted state ). The molecular switch from H4 acetylation at the FosB promoter acutely to H3 acetylation chronically is a major finding of this study. The molecular basis of this switch is not known. We found no evidence that acute or chronic cocaine administration alters levels of specific HDACs in striatum (data not shown), which suggests that the underlying mechanisms may be quite complex.
Chromatin Remodeling at the BDNF and Cdk5 Promoters: Two Target Genes for Chronic Cocaine The BDNF and Cdk5 genes show evidence of activation after chronic cocaine administration, with no regulation seen after acute cocaine. These observations are consistent with the induction of these genes in striatum after chronic, but not acute, cocaine exposure (Bibb et al., 2001; Grimm et al., 2003; McClung and Nestler, 2003) . Moreover, in contrast to FosB, where the increased levels of H3 acetylation that occur with chronic cocaine injections revert to control within a few hours, this same histone modification at the BDNF and Cdk5 promoters persists for at least 24 hr after the last cocaine injection. This histone modification increases significantly further at the BDNF gene after 1 week of withdrawal from cocaine, whereas it begins to recover toward normal levels at the Cdk5 gene. To our knowledge, these are the most long-lived examples of drug-induced chromatin remodeling in brain published to date. The data show that changes induced in chromatin structure persist long after cocaine is removed from the system and raise the critical question of the underlying mechanisms involved. We provide evidence here that, at least for the Cdk5 gene, DFosB is one critical factor that may drive some of these changes in chromatin remodeling. Such long-lived changes in chromatin remodeling might be one of the crucial mechanisms for cocaine-induced neuroadaptations in striatum, which mediate the neural and behavioral plasticity that underlies cocaine addiction.
Direct Evidence that Cdk5 Is a Target Gene for DFosB in Striatum In Vivo Using ChIP, we provide direct evidence that, after a course of chronic, but not acute, cocaine administration, there is the selective association of the Cdk5 gene promoter with DFosB. We show further that the inducible overexpression of DFosB in striatum of adult bitransgenic mice, which is sufficient for induction of Cdk5 expression in vivo (Bibb et al., 2001) , causes increased association of DFosB with the Cdk5 gene. Moreover, association of DFosB with the Cdk5 gene is associated with increased binding of Brg1-containing SWI-SNF chromatin remodeling proteins to the Cdk5 promoter. Together, these data support a scheme whereby the gradual accumulation of DFosB, in response to chronic cocaine administration, recruits chromatin remodeling factors to its target genes like Cdk5. Such factors would include the HATs that lead to H3 acetylation as well as Brg1 and other components of the SWI-SNF complex. These factors then act to reorganize histone-DNA interactions to facilitate transcription (see Narlikar et al., 2002) . In contrast to Cdk5, we found no evidence for increased association of DFosB or Brg1 with the BDNF gene. This is consistent with the evidence that DFosB does not regulate BDNF gene expression in striatum (McClung and Nestler, 2003) . Presumably, chronic cocaine leads to the long-term induction of BDNF via a distinct mechanism. One possibility is the transcription factor CREB, which is activated in a sustained fashion by chronic cocaine and, upon its inducible overexpression in striatum, can induce BDNF (McClung and Nestler, 2003) .
It is worth emphasizing the technical advances made possible by ChIP assays. Before the advent of this technology, studies of gene regulation in the brain in vivo were severely limited. For example, it was possible to demonstrate that levels of Cdk5 mRNA expression could be increased by chronic cocaine and that this effect could be mimicked upon overexpression of DFosB (Bibb et al., 2001) . However, all studies of underlying mechanisms would have to be performed in vitro, where it was possible to show that the Cdk5 gene promoter contains an AP1 site that binds DFosB and that DFosB could activate the Cdk5 promoter in cell culture (Chen et al., 2000) . Now, with ChIP, it is possible for the first time to study such transcriptional mechanisms in the brain in vivo and understand, with increasing complexity, how chronic cocaine administration leads to the long-term regulation of its target genes.
HDAC Modulation Affects Biochemical and Behavioral Responses to Cocaine
HDAC inhibitors cause increased acetylation of histones in intact cells and are being explored as treatments for several diseases, such as certain cancers (Marks et al., 2001 ), Huntington's disease (Steffan et al., 2001; Ferrante et al., 2003; Hockly et al., 2003) , and spinal muscular atrophy (Chang et al., 2001; Minamiyama et al., 2004) . We used sodium butyrate, a nonspecific HDAC inhibitor, to explore whether the changes in histone acetylation observed in this study are relevant for cocaine's biochemical and behavioral effects. We found that administration of sodium butyrate itself does not increase global levels of histone acetylation in striatum as measured immunohistochemically. Furthermore, while cocaine administration alone increases H3 phosphoacetylation in striatum, coadministration of sodium butyrate and cocaine results in a synergistic effect. A very similar pattern was observed for cocaine induction of both cFos mRNA and increased association of acetylated H3 with the cFos gene promoter: both showed synergistic responses following the coadministration of sodium butyrate and cocaine. This establishes a very clear correlation between changes in histone acetylation and regulation of gene expression in striatum. A similar correlation was also evident for the behavioral effects of cocaine: administration of sodium butyrate, at a dose that did not alter locomotor activity, almost doubled the locomotor response to cocaine.
The potentiation of cocaine's behavioral effects by HDAC inhibition was also seen in the conditioned place preference assay, which provides a measure of cocaine reward. Here, we showed that TSA, a more potent and structurally distinct HDAC inhibitor compared to butyrate, increased the place conditioning effects of cocaine. Importantly, overexpression of HDAC4, achieved via viral-mediated gene transfer, had the opposite effect: a dramatic reduction in cocaine place conditioning. Moreover, we overexpressed HSV-HDAC4 within the nucleus accumbens selectively. This experiment thereby provides a critical causal connection between the regulation of histone acetylation in this brain region specifically and an animal's sensitivity to the behavioral effects of cocaine. The fact that HDAC inhibition increases sensitivity to cocaine, and HDAC overexpression produces the opposite effect, is not an obvious finding, since cocaine causes complex effects on gene expression, with gene induction and repression both observed (e.g., see McClung and Nestler, 2003) . Our findings are therefore interesting, because they suggest that stimulation of gene transcription may be the predominant mechanism for cocaine-induced behavioral plasticity.
In summary, we show here that individual histone modifications are associated with different transcriptional regulatory mechanisms after acute or chronic cocaine administration. Previous work has shown that several histone modifications can take place in concert, either on the same histone tail (Cheung et al., 2000; Clayton et al., 2000) or on tails of different histones (Turner et al., 1992; Zeitlin et al., 2001; Sun and Allis, 2002) . Thus, specific combinations of histone modifications could correspond to various states of remodeled chromatin and to the activation or repression of distinct sets of genes. This has been termed the ''histone code'' (Jenuwein and Allis, 2001; Turner, 2002) . Results of the present study raise the interesting possibility that acute versus chronic cocaine administration causes distinct patterns of histone modifications, which, together with ATP-dependent chromatin remodeling complexes, induce unique patterns of chromatin remodeling at the promoters of certain genes to regulate their transcription. Such regulation provides a new layer of complexity, at the molecular level, through which cocaine produces neural and behavioral plasticity, and reveals mechanisms for the treatment of cocaine addiction that involve interfering with this plasticity.
Experimental Procedures Animals
All animal procedures were in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by our IA-CUC. Male Sprague-Dawley rats (initial weight, 250 g; Charles River, Kingston, RI), Bl6/C57 mice (10-12 weeks old; JAX, Bar Harbor, ME), and DFosB mutant mice off and on doxycycline (10-14 weeks old)-under conditions that maximally induce DFosB (Kelz et al., 1999 )-were used in these studies. The animal colonies were kept on a 12 hr light/dark cycle. Mice were housed in groups (four per cage), while rats were housed in pairs; food and water were made available ad libitum.
Cocaine Treatments
Acute: rats were given a single i.p. injection of 20 mg/kg cocaine or saline in equal volumes and killed 30 min to 24 hr later. Chronic: rats were given an i.p. injection of 20 mg/kg cocaine or saline once daily for 7 days and were killed 1 hr, 24 hr, or 7 days later. SelfAdministration: rats were trained for cocaine self-administration according to published procedures for 15 days (Sutton et al., 2003) . Control rats could press the same levers, but they administered only saline. The average intake of cocaine was 40 mg/kg/day. Animals were killed 24 hr after the last self-administration session. Brains were removed rapidly from decapitated animals and processed immediately for ChIP.
Chromatin Immunoprecipitation Assays
ChIP assays were performed on the basis of a protocol from Upstate Biotechnology ChIP kit (Upstate Biotechnology, Lake Placid, NY) and modified using published methods (Johnson and Bresnick, 2002; Wells and Farnham, 2002; Tsankova et al., 2004) . The following antibodies were used: anti-acetylated H3 raised against acetylated K9 and 14 H3; anti-acetylated H4 raised against acetylated K5, 8, 12, and 16 H4; phosphoacetylated H3 raised against phosphorylated S10 and acetylated K14 H3; anti-Brg1; and nonimmune rabbit and mouse IgG (all from Upstate Biotechnology). For DFosB ChIP pulldown, first, the chromatin was incubated overnight with mouse anti-FosB (C-terminal antibody; Center for Biomedical Inventions, University of Texas Southwestern Medical School), which recognizes full-length FosB only, and then with by rabbit anti-FosB (SC048; Santa Cruz Biotechnology, Santa Cruz, CA), which recognizes the middle region of both full-length FosB and DFosB. However, since virtually all of the full-length FosB is pulled down by the C-terminal antibody, the second immunoprecipitation brings down DFosB only.
Quantification of Chromatin Immunoprecipitation by Real-Time PCR Levels of specific histone modifications, Brg1, or DFosB at each gene promoter of interest were determined by measuring the amount of that gene in chromatin immunoprecipitates by use of real-time PCR (ABI Prism 7700; Applied Biosystems, CA) (see Table  S1 for primers used, in the Supplemental Data available with this article online). Input or total DNA (nonimmunoprecipitated) and immunoprecipitated DNA were PCR amplified in triplicate in the presence of SYBR Green (Applied Biosystems, CA). Ct values from each sample were obtained using the Sequence Detector 1.1 software. Relative quantification of amplified template was performed as described earlier by (Chakrabarti et al., 2002) and by the ABI manual and with some modifications (see Tsankova et al., 2004 for details). Each real-time PCR reaction, run in triplicate for each brain sample, was repeated at least twice independently.
RNA Isolation and RT-PCR Detection of cFos mRNA
Rats were treated with saline-saline, saline-cocaine, butyratesaline, and butyrate-cocaine using 15 mg/kg cocaine and 200 mg/kg sodium butyrate, both administered i.p. Striatal dissections were obtained from decapitated rats, and one punch from each rat from each of the four groups was used for isolating total RNA (remaining punches were used for ChIP assays). RNA was processed, reverse-transcribed to cDNA using a first-strand synthesis kit (Invitrogen, Carlsbad, CA), and quantified using real-time PCR as described (Tsankova et al., 2004) . PCR reactions were repeated at least two times independently.
Immunohistochemistry Rats, randomized into four groups as outlined above (saline-saline, sodium butyrate-saline, saline-cocaine, and sodium butyratecocaine) were perfused with 4% paraformaldehyde 30 min after the last injection, fixed brains were sectioned, and coronal sections through striatum were stained immunohistochemically with an anti-phosphoacetylated H3 polyclonal rabbit antibody (Upstate Biotechnology) and a fluorescent Cy3 secondary antibody. Brain sections were also stained immunohistochemically using HRP-tagged secondary antibody and diaminobenzidine (DAB), which yielded equivalent results. DAB-stained sections were used to quantify the number of phosphoacetylated H3-positive nuclei. Several sections from each animal were used for quantification. Only the antiphosphoacetylated H3 antibody was used, since the anti-acetylated H3 or H4 antibodies did not work satisfactorily in immunohistochemistry.
Locomotor Activity Assay Spontaneous locomotor activity was monitored in a circular corridor as described (Rahman et al., 2003) . Animals were randomized into four groups (saline/saline, sodium butyrate/saline, saline/cocaine, and sodium butyrate/cocaine) and habituated to the locomotor activity apparatus for 60 min. The next day, animals were habituated to the apparatus for 30 min; then they received their first injection (vehicle or sodium butyrate 100 mg/kg i.p.), and remained in the activity apparatus for 20 min. They were then given the second injection (vehicle or cocaine 15 mg/kg) and placed in the apparatus for an additional 60 min. The process was repeated for a second day. Data were analyzed by two-way ANOVA (sodium butyrate 3 cocaine) for main effects and interaction effect. For multiple comparisons, one-way ANOVA with post hoc tests was performed.
Virus-Mediated Gene Transfer HDAC4 cDNA, a gift from Dr. Eric Olson at UT Southwestern, was sub-cloned and packaged into a published bicistronic HSV-GFP viral vector (Clark et al., 2002; Barrot et al., 2002) . Activity of the vector was verified by demonstrating HDAC4 expression in PC12 cells by immunoblotting (data not shown). HSV-HDAC4 or HSV-GFP (used as a control) vectors were injected into the mouse nucleus accumbens by stereotaxic surgery. Mice were used because a single injection of virus can infect a much larger portion of the nucleus accumbens and thereby induce a greater behavioral effect. The following coordinates were used: +1.6 mm A/P, +1.5 mm lateral, and 24.4 mm D/V from bregma (relative to dura). Mice were anesthetized, virus was delivered bilaterally using a pump (at a rate of 0.1 ml/min for a total volume of 0.5 ml on each side), and behavior was tested 3-5 days after viral injection, when transgene expression is maximal (Barrot et al., 2002) .
Conditioned Place Preference Behavior
Place conditioning was conducted as described (Rahman et al., 2003) . For the TSA experiments, mice received either TSA (2 mg/ kg of body weight i.p.) or DMSO 30 min prior to the saline or cocaine (5 mg/kg) injection. Conditioning involved one pairing a day for 4 days with the test conducted on day 5. TSA was formulated as 2 mg/ml in DMSO and then diluted 1:5 with phosphate-buffered saline. DMSO was diluted similarly for the vehicle control group. For the HSV experiments, HSV-HDAC4-or HSV-GFP-injected mice were paired four times on two consecutive days, followed by testing on days 3-5 of viral injection.
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